Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DK001 in complex perianal fistulas in non/low-activity Crohn's disease (phase III)
CTR20244264Phase 3Active
- Sponsor
- Jiangsu Dekang Biotechnology
- Start
- Dec 2024
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Stem Cell Therapies → Cell Therapies, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of DK001 in Crohn's disease, sponsored by Jiangsu Dekang Biotechnology. Started Dec 2024; status: active.
02
Drugs
DK001
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20244264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244264.